(Q35566921)

8 August 2017

0 references

Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis (English)

1 reference

8 August 2017

1 reference

1 reference

1 reference

5

Peter von Dadelszen

1 reference

8 August 2017

1

Laura A Magee

1 reference

8 August 2017

4

Arne Ohlsson

1 reference

8 August 2017

Chris Cham

2

1 reference

PubMed ID

14576246

8 August 2017

Elizabeth J Waterman

series ordinal

3

1 reference

PubMed ID

14576246

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

8 August 2017

1 reference

8 August 2017

327

1 reference

8 August 2017

7421

1 reference

8 August 2017

955-960

1 reference

Drugs for treatment of very high blood pressure during pregnancy.

8 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

The detection, investigation and management of hypertension in pregnancy: executive summary

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Treatment of hypertension in patients with pre-eclampsia: a prospective parallel-group study comparing dihydralazine with urapidil

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Use of glucagon to treat neonatal low-output congestive heart failure after maternal labetalol therapy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

The effect of low-dose dihydrallazine on the fetus in the emergency treatment of hypertension in pregnancy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Comparison of labetalol and dihydralazine in hypertensive emergencies of pregnancy.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Magnesium plus nifedipine: potentiation of hypotensive effect in preeclampsia?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Nifedipine in acute hypertensive emergencies in pregnancy.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Neuromuscular blockade with magnesium sulfate and nifedipine

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

A comparative study of the use of epoprostenol and dihydralazine in severe hypertension in pregnancy

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Fetal death following labetalol administration in pre-eclampsia

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Antihypertensive drug effects on placental flow velocity waveforms in pregnant women with severe hypertension.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Nifedipine or hydralazine as a first-line agent to control hypertension in severe preeclampsia

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Effect of Urapidil in antihypertensive therapy of preeclampsia on newborns

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Fortnightly review: management of hypertension in pregnancy

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Malignant ventricular arrhythmias in eclampsia: a comparison of labetalol with dihydralazine.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Intravenous isradipine in the management of severe hypertension of pregnancy in black patients: a pilot study.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Intravenous isradipine in the management of severe hypertension in pregnant and nonpregnant patients. A pilot study.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Effect of dihydralazine on the fetus in the treatment of maternal hypertension.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Intravenous labetalol and intravenous dihydralazine in severe hypertension in pregnancy.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=259162

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy

26 September 2018

1 reference

12 December 2020

Nifedipine in the treatment of severe preeclampsia

1 reference

12 December 2020

Maternal and fetal haemodynamics in hypertensive pregnancies during maternal treatment with intravenous hydralazine or labetalol

1 reference

12 December 2020

[Management of severe pre-eclampsia/eclampsia. Comparison between nifedipine and hydralazine as antihypertensive agents]

1 reference

12 December 2020

Hypertension in pregnancy

1 reference

12 December 2020

Ketanserin and hydralazine in hypertension in pregnancy--a randomised double-blind trial

1 reference

12 December 2020

Sublingual nifedipine compared with intravenous hydrallazine in the acute treatment of severe hypertension in pregnancy: potential for use in rural practice

1 reference

12 December 2020

Management of severe preeclampsia

1 reference

12 December 2020

Withdrawal of nifedipine capsules: jeopardizing the treatment of acute severe hypertension in pregnancy? Australasian Society for the Study of Hypertension in Pregnancy

1 reference

12 December 2020

Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results

1 reference

12 December 2020

Calcium-channel blockers for hypertension--uncertainty continues

1 reference

12 December 2020

Oral nifedipine therapy in the management of severe preeclampsia.

1 reference

12 December 2020

Ketanserin versus dihydralazine in the management of severe early-onset preeclampsia: maternal outcome

1 reference

12 December 2020

A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.327.7421.955

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

PubMed ID

14576246